NZ244149A - Kedarcidin chromophore and pharmaceutical compositions. - Google Patents
Kedarcidin chromophore and pharmaceutical compositions.Info
- Publication number
- NZ244149A NZ244149A NZ244149A NZ24414992A NZ244149A NZ 244149 A NZ244149 A NZ 244149A NZ 244149 A NZ244149 A NZ 244149A NZ 24414992 A NZ24414992 A NZ 24414992A NZ 244149 A NZ244149 A NZ 244149A
- Authority
- NZ
- New Zealand
- Prior art keywords
- kedarcidin
- chromophore
- methanol
- exhibits
- kedarcidin chromophore
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/763,465 US5143906A (en) | 1991-09-26 | 1991-09-26 | Kedarcidin antitumor chromophore and pharmaceutical composition containing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ244149A true NZ244149A (en) | 1994-01-26 |
Family
ID=25067899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ244149A NZ244149A (en) | 1991-09-26 | 1992-08-31 | Kedarcidin chromophore and pharmaceutical compositions. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5143906A (ref) |
| EP (1) | EP0534137A3 (ref) |
| JP (1) | JPH06179623A (ref) |
| KR (1) | KR930005632A (ref) |
| CN (1) | CN1032235C (ref) |
| AU (1) | AU647300B2 (ref) |
| CA (1) | CA2075453A1 (ref) |
| FI (1) | FI923827A7 (ref) |
| HU (1) | HU211108B (ref) |
| IL (1) | IL102942A0 (ref) |
| MX (1) | MX9204765A (ref) |
| NO (1) | NO178892C (ref) |
| NZ (1) | NZ244149A (ref) |
| PL (1) | PL168918B1 (ref) |
| RU (1) | RU2067117C1 (ref) |
| TW (1) | TW215900B (ref) |
| ZA (1) | ZA926421B (ref) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3706729A (en) * | 1963-11-21 | 1972-12-19 | Andrew David Batcho | Antibiotics and processes for their preparation |
| US5001112A (en) * | 1988-04-12 | 1991-03-19 | Bristol-Myers Company | Antitumor antibiotic kedarcidin |
-
1991
- 1991-09-26 US US07/763,465 patent/US5143906A/en not_active Expired - Fee Related
-
1992
- 1992-05-13 TW TW081103762A patent/TW215900B/zh active
- 1992-08-05 AU AU20800/92A patent/AU647300B2/en not_active Ceased
- 1992-08-06 CA CA002075453A patent/CA2075453A1/en not_active Abandoned
- 1992-08-17 RU SU925052758A patent/RU2067117C1/ru active
- 1992-08-18 MX MX9204765A patent/MX9204765A/es unknown
- 1992-08-19 HU HU9202712A patent/HU211108B/hu not_active IP Right Cessation
- 1992-08-20 NO NO923260A patent/NO178892C/no unknown
- 1992-08-20 EP EP19920114277 patent/EP0534137A3/en not_active Ceased
- 1992-08-21 JP JP4264030A patent/JPH06179623A/ja active Pending
- 1992-08-25 PL PL92295725A patent/PL168918B1/pl unknown
- 1992-08-25 ZA ZA926421A patent/ZA926421B/xx unknown
- 1992-08-25 IL IL102942A patent/IL102942A0/xx unknown
- 1992-08-26 FI FI923827A patent/FI923827A7/fi not_active Application Discontinuation
- 1992-08-26 CN CN92110256A patent/CN1032235C/zh not_active Expired - Fee Related
- 1992-08-26 KR KR1019920015415A patent/KR930005632A/ko not_active Ceased
- 1992-08-31 NZ NZ244149A patent/NZ244149A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI923827A0 (fi) | 1992-08-26 |
| EP0534137A3 (en) | 1994-07-06 |
| NO178892B (no) | 1996-03-18 |
| IL102942A0 (en) | 1993-01-31 |
| ZA926421B (en) | 1993-03-01 |
| HUT62908A (en) | 1993-06-28 |
| NO923260L (no) | 1993-03-29 |
| AU647300B2 (en) | 1994-03-17 |
| MX9204765A (es) | 1993-03-01 |
| NO178892C (no) | 1996-06-26 |
| JPH06179623A (ja) | 1994-06-28 |
| PL295725A1 (en) | 1993-04-05 |
| HU211108B (en) | 1995-10-30 |
| CN1032235C (zh) | 1996-07-10 |
| RU2067117C1 (ru) | 1996-09-27 |
| FI923827L (fi) | 1993-03-27 |
| TW215900B (ref) | 1993-11-11 |
| PL168918B1 (pl) | 1996-05-31 |
| AU2080092A (en) | 1993-04-01 |
| CA2075453A1 (en) | 1993-03-27 |
| KR930005632A (ko) | 1993-04-20 |
| FI923827A7 (fi) | 1993-03-27 |
| EP0534137A2 (en) | 1993-03-31 |
| CN1073447A (zh) | 1993-06-23 |
| NO923260D0 (no) | 1992-08-20 |
| US5143906A (en) | 1992-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69012384T2 (de) | BMY-41950-Antitumor-Antibiotikum. | |
| JPS61197585A (ja) | 新規なブリオスタチン４〜８ | |
| CA1060003A (en) | N-trifluoroacetyladriamycin-14-alkanoates and therapeutic compositions containing same | |
| US4064014A (en) | Antibiotic compounds marcellomycin and musettamycin | |
| SU1586521A3 (ru) | Способ получени производных гликопептидов | |
| RU2032693C1 (ru) | N-алкилпроизводные антибиотиков или их фармацевтически приемлемые соли, обладающие противогрибковой активностью, соединение в качестве промежуточного соединения в синтезе n-алкилпроизводных антибиотиков и способ получения n-алкилпроизводных антибиотика или их фармацевтически приемлемых солей | |
| FI75173B (fi) | Foerfarande foer framstaellning av nya cytostatiskt verkande antracyklinderivat. | |
| Berger et al. | Coumarin-glycoside antibiotics | |
| US5143906A (en) | Kedarcidin antitumor chromophore and pharmaceutical composition containing same | |
| US4237225A (en) | Process for preparing tunicamycin | |
| US4360595A (en) | Fermentation process for producing anandimycin | |
| Argoudelis et al. | New paulomycins produced by Streptomyces paulus | |
| EP0491956A1 (en) | Reveromycin a, production thereof, and antitumor drug and fungicide | |
| CN108676013B (zh) | 具有自噬激活活性的黄醇酮类化合物、其制备方法及其制药应用 | |
| EP0532156A1 (en) | Physiologically active diterpenoid | |
| Strauss et al. | Leukaemomycin, an antibiotic with antitumor activity. II. Isolation and identification | |
| CN112500348A (zh) | 一类格尔德霉素衍生物及其制备方法和在制备抗肿瘤药物中的应用 | |
| US5451581A (en) | Antibiotic LL-14E605β and O-methyl-LL-14E605β | |
| CN105732711B (zh) | 2(1h)‑喹啉酮磷酸酯衍生物及其制备方法和应用 | |
| US4162938A (en) | Antibiotic compound | |
| CN113480557B (zh) | 聚酮类化合物及其制备方法和在制备抗肿瘤药物中的应用 | |
| JP3502655B2 (ja) | 制癌性抗生物質チアジノトリエノマイシン及びその製造法 | |
| AU682543B2 (en) | Antitumor antibiotics | |
| US3219544A (en) | Process for producing antibiotic | |
| DE69904797T2 (de) | Antibakterielle Furopyridine |